Revelation Biosciences (REVB) Prepaid Assets (2020 - 2026)
Revelation Biosciences (REVB) recorded Prepaid Assets of $201,724 in Q2 2026, up 8.4% from $186,049 a year earlier and up 117.8% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Prepaid Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences reported Prepaid Assets of $111,297, up 66.9% from FY2024.
- Annual Prepaid Assets has a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
- Across earlier years, Prepaid Assets came in at $66,699 in FY2024 (-21.2%), $84,691 in FY2023 (+15.8%), $73,132 in FY2022 (-88.5%) and $637,342 in FY2021 (+457.8%).
- The Q2 2026 figure is the highest quarterly Prepaid Assets since Q1 2025.
- On a year-over-year basis, Prepaid Assets rose in five of the last eight quarters, with growth averaging 29.6%.
- Peak year-over-year performance for Prepaid Assets in the last five years was growth of 700.1% in Q2 2022, against a decline of 88.5% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $92,620 (Q1 2026), $111,297 (Q4 2025) and $123,934 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201,724.00 |
| Mar 31, 2026 | 92,620.00 |
| Dec 31, 2025 | 111,297.00 |
| Sep 30, 2025 | 123,934.00 |
| Jun 30, 2025 | 186,049.00 |
| Mar 31, 2025 | 223,270.00 |
| Dec 31, 2024 | 66,699.00 |
| Sep 30, 2024 | 117,846.00 |
| Jun 30, 2024 | 125,743.00 |
| Mar 31, 2024 | 71,876.00 |
| Dec 31, 2023 | 84,691.00 |
| Sep 30, 2023 | 152,637.00 |
| Jun 30, 2023 | 250,012.00 |
| Mar 31, 2023 | 332,387.00 |
| Dec 31, 2022 | 73,132.00 |
| Sep 30, 2022 | 309,628.00 |
| Jun 30, 2022 | 575,481.00 |
| Mar 31, 2022 | 684,780.00 |
| Dec 31, 2021 | 637,342.00 |
| Sep 30, 2021 | 19,334.00 |
API Access
Revelation Biosciences Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();